Masamitsu Kanada is an Assistant Professor in the Department of Pharmacology and Toxicology. His research focuses on addressing questions in cancer biology using multidisciplinary approaches.
Dr. Kanada received his Ph.D. from Tsukuba University in Japan. After completing his Ph.D., he worked for a pharmaceutical company developing cancer therapies. During his postdoctoral training, Dr. Kanada learned intravital microscopy and whole-body preclinical imaging at Hamamatsu University School of Medicine and Stanford University.
Dr. Kanada's lab is focused on understanding and controlling extracellular vesicle (EV)-mediated cancer-host crosstalk in the body. The Kanada Lab is currently developing multiscale EV imaging techniques to determine how EVs impact various aspects of cancer progression. The team is also developing an EV-based gene delivery system that could be a safe and effective gene therapy approach for cancer patients.